PATIENTS aged 75 and older who abandon statin treatment for high cholesterol have an increased risk of suffering a cardiovascular event, research published in the European Heart Journal reveals.
Data showed that statin discontinuation was associated with a 33% increased risk of admission for cardiovascular event in 75-year-old primary prevention patients.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Aug 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Aug 19
